These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
346 related items for PubMed ID: 2810973
21. [Alveolar lymphocyte proliferation in sarcoidosis patients induced by Propionibacterium acnes]. Nakata Y, Ejiri T, Kishi T, Kabayashi Y, Fujita M, Ohnoshi T, Kimura I. Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Apr; 23(4):413-9. PubMed ID: 4046241 [No Abstract] [Full Text] [Related]
23. Lack of correlation between serum angiotensin-converting enzyme activity and bronchoalveolar lymphocytosis in lung sarcoidosis. Radermecker M, Gustin M, Saint-Remy P. Eur J Respir Dis; 1984 Apr; 65(3):189-95. PubMed ID: 6327344 [Abstract] [Full Text] [Related]
32. Altered immunological reactivity in alveolar macrophages from patients with sarcoidosis. Gallagher RB, Guckian M, van Breda A, Odlum C, Fitzgerald MX, Feighery C. Eur Respir J; 1988 Feb; 1(2):153-60. PubMed ID: 2966072 [Abstract] [Full Text] [Related]
33. Interrelationship between bronchoalveolar lavage cellular constituents and pulmonary functions in sarcoidosis. Sharma SK, Pande JN, Verma K, Guleria JS. Indian J Chest Dis Allied Sci; 1989 Feb; 31(2):77-84. PubMed ID: 2606549 [Abstract] [Full Text] [Related]
34. Antigen-induced proliferative response of lavage and blood T lymphocytes. Comparison of cells from normal subjects and patients with sarcoidosis. Lecossier D, Valeyre D, Loiseau A, Cadranel J, Tazi A, Battesti JP, Hance AJ. Am Rev Respir Dis; 1991 Oct; 144(4):861-8. PubMed ID: 1928963 [Abstract] [Full Text] [Related]
35. [Spontaneous interleukin 1 secretion by alveolar macrophages from the bronchoalveolar lavage of patients with active sarcoidosis]. Barth J, Kreipe H, Radzun HJ, Schumacher U, Petermann W. Immun Infekt; 1989 Aug; 17(4):141-4. PubMed ID: 2789181 [Abstract] [Full Text] [Related]
36. [T-lymphocyte subpopulations in bronchoalveolar lavage in pulmonary sarcoidosis and other interstitial pulmonary diseases]. Petrek M, Kolek V. Cas Lek Cesk; 1993 Jun 14; 132(12):365-8. PubMed ID: 8343944 [Abstract] [Full Text] [Related]
37. [Use of flow cytometry in evaluation of cellular changes in interstitial lung diseases]. Kopiński P. Folia Med Cracov; 1997 Jun 14; 38(3-4):69-115. PubMed ID: 10481384 [Abstract] [Full Text] [Related]
38. Suppressive mechanisms of alveolar macrophages in interstitial lung diseases: role of soluble factors and cell-to-cell contact. Fireman E, Ben-Efraim S, Spinrad S, Topilsky M, Greif J. Eur Respir J; 1993 Jul 14; 6(7):956-64. PubMed ID: 8370444 [Abstract] [Full Text] [Related]
39. Cellular components of the bronchoalveolar lavage correlate with lung function impairment and extrapulmonary involvement markers in active sarcoidosis. Chorostowska-Wynimko J, Leśniewska-Radomska D, Krychniak-Soszka A, Remiszewski P, Szopiński J, Wesołowski S, Kuś J, Skopińska-Rózewska E. J Physiol Pharmacol; 2004 Sep 14; 55 Suppl 3():41-7. PubMed ID: 15611592 [Abstract] [Full Text] [Related]